TrialCancer research communications2026

Lenvatinib plus Pembrolizumab for Patients with Previously Treated Advanced Gastric, Biliary Tract, or Pancreatic Cancer: Results from the Phase II LEAP-005 Study.

Mariano Ponz-Sarvisé et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.